ÃâÒßѧÊÔÌâ
W24bO|>D Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
yjq
)}y,tF 1. Fas(CD95)/FasL
+7^Ul6BB#K 2. common chain of cytokine receptor
4.'EEuRw\} 3 . TCR/CD3 complex
zEW:Xe) 4. negaive selection of thymocytes
a{+oN
$ 5. artificial active immune
|DW'RopM 6. anti-idiotypic
76b7-Nj" 7. IgSF
!iVFz
G
@m 8. Integrin
LXLDu2/@ 9. chemokine
SDIeq 10. B7/CD28
2M?
lgh4" ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
d_+8=nh3 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
M9#QS`G 2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
/aG>we 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
Lf#G
?]@ 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
Wu( 8G
*fSM' q; 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
^-u HdafP µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
_o
TT3[7P Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
es[5B* 5 1. B7/CD28
=h::VB}Lv 2. Th1 subset
(QSWb>np 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
1bg@[YN!; 4. antibody affinity maturation
uV_)JZW,L 5. AP-1
4~A#^5J 6. single chain variable fragment£¨ScFv£©
df6Ν4L 7. NK cell receptor
0 jP00 8. Zinkernagel-Doherty phenomenon
mN{ajf)@ 9. Ig fold
Y-q@~vZ] 10. CD40/CD40L
9]@J*A}=l ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
W}k?gg= 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
l5';?>!s 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
hcd>A vC8 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
yp{F8V 8 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
@MZ6E$I 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
5u)^FIBj 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
5Vnr"d 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
4 uy @ { Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
9`
CiE £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
KPjqw{gR_R Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
ONN{4&7@< 1.Co-stimulators (or co-stimulating molecules)
|<3Q+EB^ 2.NK-kB
$sc8)d\B 3.Immunoglobulin superfamily
:
qCm71* 4.antigen-presenting cell (APC)
nhP~jJn 5.death domain
/i
k)4]> 6.CCR and CXCR
fteyG$-s 7.Lectin (or mitogen)
_WDBG 8.Clusters of differentiation, CD)
GATP 9.B7 family
dVVvG] 10.Cytotoxic T lymphocyte, CTL)
Z;Ir>^< 11.IL-15 and IL-15 receptor (IL-15R)
8g#
Y 12.MHC restriction
R5NRCI 13.Affinity-chromatography
t|#NMRz 14.Cyctosprin A, CsA
qN1e{T8u 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
1FD7~S| ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
1(:b{Bl 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
\2gvp6 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
iC\rhHKQ 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
mq{$9@3 Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
;Z!~A"~$> ÃâÒßѧרҵ£º
*C3uMiz 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
EbBv}9g Ïû»¯ÄÚ¿Æ£º
Imh2~rw; 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
vGPf`2/j. ѪҺ²¡Ñ§×¨Òµ£º
{p#l!P/ 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
>%n8W>^^4 Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
YoV^xl6g (רҵ»ù´¡: ÃâÒßѧ)
lnS\5J Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
0,1L e$)6 1. ADCC(antibody dependent cell-mediated cytotoxicity)
FhY{;-W(T 2. »·æß¾úËØ(cyclosporin)
v|4STR 3. KIR(killer cell inhibitory receptor)
vk4C_8m 4. HLDA(human leucocyte differentiation antigen)
0^<Skm27" 5. Interleukin 18(IL-18)
Y91
e1PsV 6. ÕûºÏËØ(integrin)
="5k\1W1M 7. Fas/FasL
Z%Tq1O 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
O:`GL1{ve? 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
zx\.2<K 10. Th1/Th2
*tTP8ZCQ[ 11. »ùÒòÒßÃç(DNAÒßÃç)
2p$n*|T&c 12. chemokines and chemokine receptor
<O,'5+zG% 13. ÃâÒßÄÍÊÜ
2cs?("8e% 14. ¹²´Ì¼¤·Ö×Ó
2|0Je^$|
15. ËÀÍö½á¹¹Óò(death domain)
Qm
WC2$b ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
%gV)arwK 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
5}-)vsa` 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
"J]f0m= £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
E<D+)A £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
pTa'.m £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
T!m42EvIvE £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
-{yDk$" 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
FX7Cjo#=R Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
2k.S[?) ÎÊ´ðÌâ(ÿÌâ25·Ö)
]uBT & 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
paq8L{R 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
kbfuvJ> 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
q6;OS.f 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£